Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010254 | 1.00 | GSR (0.42) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL6010168 | 0.85 | GSR (0.43) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL21855295 | 0.80 | GSR (0.39) | GSRRNPEPCPB2FOLH1 | |
| SCHEMBL6009873 | 0.80 | CPB2 (0.38) | GSRRNPEPCPB2 | |
| SCHEMBL21855294 | 0.79 | GSR (0.38) | GSRRNPEPCPB2FOLH1 | |
| SCHEMBL146746 | 0.77 | GSR (0.42) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL6028111 | 0.76 | GSR (0.47) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL6028109 | 0.76 | GSR (0.47) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL1854667 | 0.75 | GSR (0.54) | GSRRNPEPCPB2FOLH1CPB1 | |
| SCHEMBL1854666 | 0.75 | GSR (0.54) | GSRRNPEPCPB2FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | GSR 809/4885RNPEP 2950/4885CPB2 3245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.